BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32317154)

  • 1. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs.
    Hedima EW; Adeyemi MS; Ikunaiye NY
    Res Social Adm Pharm; 2021 Jan; 17(1):1964-1966. PubMed ID: 32317154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward.
    Meghana A; Aparna Y; Chandra SM; Sanjeev S
    Res Social Adm Pharm; 2021 Jan; 17(1):2018-2022. PubMed ID: 32362583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
    Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
    J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
    Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
    Front Public Health; 2020; 8():561924. PubMed ID: 33364224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic.
    Hussain R; Dawoud DM; Babar ZU
    Res Social Adm Pharm; 2021 Jan; 17(1):1920-1924. PubMed ID: 32792322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulfilling an Unmet Need: Roles for Clinical Pharmacists in Preconception Care.
    DiPietro Mager NA
    Pharmacotherapy; 2016 Feb; 36(2):141-51. PubMed ID: 26846305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting against COVID-19: Innovative strategies for clinical pharmacists.
    Li H; Zheng S; Liu F; Liu W; Zhao R
    Res Social Adm Pharm; 2021 Jan; 17(1):1813-1818. PubMed ID: 32278766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 on access to healthcare in low- and middle-income countries: Current evidence and future recommendations.
    Okereke M; Ukor NA; Adebisi YA; Ogunkola IO; Favour Iyagbaye E; Adiela Owhor G; Lucero-Prisno DE
    Int J Health Plann Manage; 2021 Jan; 36(1):13-17. PubMed ID: 32857892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
    Merks P; Jakubowska M; Drelich E; Świeczkowski D; Bogusz J; Bilmin K; Sola KF; May A; Majchrowska A; Koziol M; Pawlikowski J; Jaguszewski M; Vaillancourt R
    Res Social Adm Pharm; 2021 Jan; 17(1):1807-1812. PubMed ID: 32546449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Pharmacists Roles During the COVID-19 Pandemic.
    Hess K; Bach A; Won K; Seed SM
    J Pharm Pract; 2022 Jun; 35(3):469-476. PubMed ID: 33317371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alaska pharmacists: First responders to the pandemic in the last frontier.
    Paul AK; Bogart T; Schaber AR; Cutchins DC; Robinson RF
    J Am Pharm Assoc (2003); 2021; 61(1):e35-e38. PubMed ID: 33036935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges of COVID-19 for community pharmacists and opportunities for the future.
    Hayden JC; Parkin R
    Ir J Psychol Med; 2020 Sep; 37(3):198-203. PubMed ID: 32434603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the paradigm of community pharmacy practice expected to shift due to COVID-19?
    Nadeem MF; Samanta S; Mustafa F
    Res Social Adm Pharm; 2021 Jan; 17(1):2046-2048. PubMed ID: 32565052
    [No Abstract]   [Full Text] [Related]  

  • 18. Community pharmacies and population health.
    Lavigne JE; Wright SA; Burke ES; Kirwan B; Ball J
    Am J Health Syst Pharm; 2017 Oct; 74(19):1522-1523. PubMed ID: 28947521
    [No Abstract]   [Full Text] [Related]  

  • 19. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
    Carico RR; Sheppard J; Thomas CB
    Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.